Progenics Pharmaceuticals

  www.progenics.com
  www.progenics.com

Progenics Pharmaceuticals Reviews

6 Reviews
2.0
6 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Progenics Pharmaceuticals CEO, General Counsel, Secretary, and Director Mark R. Baker
Mark R. Baker
2 Ratings
  1.  

    Mostly research small co. so no career growth

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee in Tarrytown, NY
    Former Employee - Anonymous Employee in Tarrytown, NY

    I worked at Progenics Pharmaceuticals as a contractor (less than an year)

    Pros

    Good benefits and usual holidays off as well as summer hours.

    Cons

    Various layoffs and reorganizations as nothing being marketed

    Advice to ManagementAdvice

    Too many managers

    Doesn't Recommend
    Neutral Outlook
    No opinion of CEO

Progenics Pharmaceuticals Interviews

Interview Experience

Interview Experience

100%
0%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Associate Research Scientist Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied through an employee referral. The process took a dayinterviewed at Progenics Pharmaceuticals in January 2009.

    Interview Details

    last about 2 hours. went through resume with each interviewer and they asked a few technical questions based on your resume. one of the interviewer arrived late. just chat with the hiring manager while waiting.

    Declined Offer
    Positive Experience
    Average Interview

Progenics Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.progenics.com
Headquarters Tarrytown, NY
Size 50 to 149 Employees
Founded 1986
Type Company - Public (PGNX)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

Progenics Pharmaceuticals is taking a proactive approach to fighting serious diseases. The company develops biotech drugs with oncology and virology applications, as well as therapeutics used in clinical care settings. Progenics' commercial product Relistor, which blocks the side effects of opioids without lessening their pain-killing power, is approved as an injectable treatment for opioid-induced constipation (OIC) in terminally ill patients. The drug was developed in collaboration with Wyeth Pharmaceuticals (now part of Pfizer). Also in the firm's pipeline are a... More

Work at Progenics Pharmaceuticals? Share Your Experiences

Progenics Pharmaceuticals

 
Click to Rate
or